瘤病毒在癌症免疫治疗中的临床进展
Mohammed A Zolaly1, Waleed Mahallawi2, Zakaria Y Khawaji3
1Pediatric Hematology Oncology, Taibah University, Al-Madinah al-Munawwarah, SAU.
Cureus
|July 24, 2023
概括
针对癌细胞和刺激免疫反应的瘤解毒病毒,在先进的癌症治疗中显示出前途. 临床试验正在评估它们的有效性和安全性,单独或与标准疗法一起使用.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 病毒学 病毒学
背景情况:
- 瘤病毒代表了癌症免疫疗法的新方法.
- 这些病毒经过基因工程改造,可以选择性地向和摧毁癌细胞,同时还可以刺激抗瘤免疫反应.
研究的目的:
- 审查瘤病毒在癌症治疗中的最新临床应用.
- 总结来自临床试验不同阶段的疗效和安全性数据.
主要方法:
- 用基因工程技术赋予菌体活性 (例如,囊体修饰,用IL-12武装细胞因子).
- 使用固体瘤响应评估标准 (RECIST) 评估临床结果.
- 评估与化疗,放射治疗和手术等标准治疗相结合.
主要成果:
- 瘤学病毒疗法正在研究晚期癌症.
- 临床研究评估了不同类型癌症的安全性和有效性.
- 组合疗法旨在提高治疗结果.
结论:
- 瘤病毒在瘤学中提供了一个有前途的治疗策略.
- 进一步的临床评估对于确定它们在癌症治疗范式中的作用至关重要.
相关概念视频
Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560
Cancer Vaccines
410
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
410
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cytotoxic T Cells-mediated Immune Response
977
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
977
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


